Open letter to Roche about oseltamivir trial data

Open letter to Roche about oseltamivir trial data.

Dear John I am writing to you in your capacity as a member of the board of Roche. As you may be aware, the BMJ has been working with the Cochrane Collaboration in its efforts to get Roche to release the raw data on the effects of oseltamivir (Tamiflu) so that Cochrane can properly fulfil the UK government’s commission for a systematic review of neuraminidase inhibitors based on clinical study r...

Some Points About Letter To Editor

This article has no abstract.

Open letter: European Medicines Agency should remove barriers to access clinical trial data.

Ben Goldacre research fellow in epidemiology, London School of Hygiene and Tropical Medicine, Fiona Godlee editor in chief, The BMJ, Carl Heneghan director, Centre for Evidence based Medicine, Oxford, David Tovey editor in chief, Cochrane Library, Richard Lehman general practitioner, Oxfordshire, Iain Chalmers coordinator, James Lind Initiative, Virginia Barbour medicine editorial director, PLO...

Microarray Data Standards: An Open Letter

A fundamental principle guiding the publication of scientific results is that the data supporting any scholarly work must be made fully available to the research community in a form that allows the basic conclusions to be evaluated independently. In the context of molecular biology, this has typically meant that authors of papers describing a newly sequenced genome, gene, or protein must deposi...

Letter to Editor about "hypothyroidism and Ramadan fasting"